October 24-25, 2018
Boston, USA


  • Speaker Interviews

    The following experts in the field discussed the key challenges drug developers are facing, and gave their views on the great promise for better and more efficient innovative dermatological therapies making their way into market:

    > Greg P. Licholai, President & Chief Scientific Officer, Castle Creek Pharmaceuticals

    > Tomoko Maeda-Chubachi, Senior Medical Director, Dermatology, GlaxoSmithKline

    They will be sharing their endeavors in greater depth at the Dermatology Drug Development Summit where you can engage with them personally.